UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 283

Sortiert nach

Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 1: Definition, risk factors and assessment

Journal of gastroenterology and hepatology, 2018-01, Vol.33 (1), p.70-85

2018

Volltextzugriff (PDF)

The Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 2: Management and special groups

Journal of gastroenterology and hepatology, 2018-01, Vol.33 (1), p.86-98

2018

Volltextzugriff (PDF)

P22 Endoscopic Ultrasound Guided Transgastric Shunt Occlusion (ETSO)-A Novel Method of Shunt Occlusion for Recurrent Hepatic Encephalopathy

The American journal of gastroenterology, 2023-09, Vol.118 (9S), p.S16-S17

2023

Volltextzugriff (PDF)

Fatty liver - Current and future treatment: A narrative review

Apollo medicine, 2021-10, Vol.18 (4), p.243-248

2021

Volltextzugriff (PDF)

S1083 Chronic Hepatitis C Infection Is Associated With Depression, Anxiety, and Impaired Neurocognitive Performance, Which Improves After Achieving SVR-12 With Direct-Acting Antivirals: A Prospective Study

The American journal of gastroenterology, 2021-10, Vol.116 (1), p.S511-S512

2021

Volltextzugriff (PDF)

S3411 Profile of Anaemia in Patients With Acute-on-Chronic Liver Failure

The American journal of gastroenterology, 2021-10, Vol.116 (1), p.S1401-S1402

2021

Volltextzugriff (PDF)

S3403 Assessment of Role of Iron Metabolism, Vitamin Deficiency, Gastrointestinal Blood Loss, and Chronic Inflammation in the Etiopathogenesis of Anemia in Chronic Liver Disease

The American journal of gastroenterology, 2021-10, Vol.116 (1), p.S1398-S1399

2021

Volltextzugriff (PDF)

Multidisciplinary and Integrated Treatment for Substance Use Disorders and Hepatitis C in an Addiction Treatment Service in India

Indian journal of psychological medicine, 2023-03, Vol.45 (2), p.193-197

2023

Volltextzugriff (PDF)

Proteomic-based identification of APCS as candidate protein for diagnosis of patients exhibiting anti-tubercular drug induced liver injury

Scientific reports, 2023-06, Vol.13 (1), p.10135-10135, Article 10135

2023

Volltextzugriff (PDF)

P1- HIGH VIRAL SUPPRESSION AND IMPROVED SAFETY PROFILE OF TENOFOVIR ALAFENAMIDE RELATIVE TO TENOFOVIR DISOPROXIL FUMARATE IN CHRONIC HEPATITIS B PATIENTS TREATED FOR 5 YEARS

Annals of hepatology, 2023-03, Vol.28, p.100905, Article 100905

2023

Volltextzugriff (PDF)

Association between nonalcoholic fatty liver disease and inflammatory periodontal disease: A case‑control study

Journal of Indian Society of Periodontology, 2021-01, Vol.25 (1), p.47-54

2021

Volltextzugriff (PDF)

GALAD Score for HCC Screening and Surveillance

Clinical gastroenterology and hepatology, 2023-02, Vol.21 (2), p.556-557

2023

Volltextzugriff (PDF)

Nonalcoholic Fatty Liver Disease: Indian Perspective

Clinical liver disease (Malden, Mass.), 2021-09, Vol.18 (3), p.158-163

2021

Volltextzugriff (PDF)

Su1537 MACHINE LEARNING ADVANCED FIBROSIS AND AT-RISK MASH (ALADDIN) WITH A WEB-BASED CALCULATOR FOR PROBABILITY PREDICTION

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-1629-S-1629

2024

Volltextzugriff (PDF)

Phospho zinc finger protein: A promising serum biomolecule as noninvasive diagnostic marker of chronic Hepatitis B related liver diseases including liver cancer

Journal of radiation and cancer research, 2021-01, Vol.12 (4), p.147-158

2021

Volltextzugriff (PDF)

Substantial overlap between NAFLD and MASLD with comparable disease severity and non-invasive test performance: An analysis of the Indian Consortium on MASLD (ICOM-D) cohort

Journal of hepatology, 2024-05

2024

Volltextzugriff (PDF)

I. Beta-blockers: Finding the Right Timing and its Role in Cirrhosis

Journal of clinical and experimental hepatology, 2012-06, Vol.2 (2), p.193-194

Duseja, Ajay K

2012

Volltextzugriff (PDF)

MASLD screening and diagnostic algorithms are interchangeable with existing NAFLD literature

Journal of hepatology, 2024-02, Vol.80 (2), p.e89-e91

2024

Volltextzugriff (PDF)

Special Population

Clinics in liver disease, 2023-05, Vol.27 (2), p.451-469

2023

Volltextzugriff (PDF)

Obesity and NAFLD

Clinics in liver disease, 2014-02, Vol.18 (1), p.59-71

2014

Volltextzugriff (PDF)

Role of radiofrequency ablation in unresectable hepatocellular carcinoma: An Indian experience

The Indian journal of radiology & imaging, 2013-04, Vol.23 (2), p.139-144

2013

Volltextzugriff (PDF)

Mo1537 NIAAA CLINICAL CRITERIA FOR THE DIAGNOSIS OF ALCOHOLASSOCIATED HEPATITIS ARE PRECISE IN SEVERE BUT NOT IN MODERATE ALCOHOL-ASSOCIATED HEPATITIS

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-1683-S-1683

2024

Volltextzugriff (PDF)

A prospective observational study on the impact of hepatic steatosis, hepatic fibrosis, and metabolic syndrome on the outcome of patients with acute pancreatitis

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2023-12, Vol.23 (8), p.e1-e2

2023

Volltextzugriff (PDF)

S1430 Saroglitazar Improves Metabolic Profile, Hepatic Steatosis, Inflammation, and Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: A Systematic Review

The American journal of gastroenterology, 2023-10, Vol.118 (10S), p.S1090-S1090

2023

Volltextzugriff (PDF)

Calorie restriction by time restricted intermittent fasting is better than standard calorie restriction in improving the metabolic profile and hepatic fibrosis in patients with non-alcoholic fatty liver disease

Journal of hepatology, 2023-06, Vol.78, p.S55

2023

Volltextzugriff (PDF)

1 – 25 von 283

Suche als RSS-Feed

Aktive Filter

ThemaLife Sciences & Biomedicine

ThemaMiddle Aged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(261)
Mit Volltextzugriff
(253)

Publikationsform

Sprache

Englisch
(282)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Gastroenterology And Hepatology
(44)
Endocrinology & Metabolism
(41)
Humans
(18)
Liver Diseases
(9)
Nonalcoholic Steatohepatitis
(5)
Risk Factors
(5)
Female
(4)
Hepatology
(4)
Liver
(4)
Liver Cirrhosis
(4)
Metabolic Syndrome
(4)
Nash
(4)
Non-Alcoholic Fatty Liver Disease - Diagnosis
(4)
Nonalcoholic Fatty Liver Disease
(4)
Ultrasonic Imaging
(4)
Adult
(3)
Care And Treatment
(3)
Endoscopy
(3)
Fatty Liver
(3)
Gastroenterology
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(40)
... seit 30 Tagen
(27)

Menü

Weitere Dienste

Einstellungen

Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 1: Definition, risk factors and assessment

The Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 2: Management and special groups

P22 Endoscopic Ultrasound Guided Transgastric Shunt Occlusion (ETSO)-A Novel Method of Shunt Occlusion for Recurrent Hepatic Encephalopathy

Fatty liver - Current and future treatment: A narrative review

S1083 Chronic Hepatitis C Infection Is Associated With Depression, Anxiety, and Impaired Neurocognitive Performance, Which Improves After Achieving SVR-12 With Direct-Acting Antivirals: A Prospective Study

S3411 Profile of Anaemia in Patients With Acute-on-Chronic Liver Failure

S3403 Assessment of Role of Iron Metabolism, Vitamin Deficiency, Gastrointestinal Blood Loss, and Chronic Inflammation in the Etiopathogenesis of Anemia in Chronic Liver Disease

Multidisciplinary and Integrated Treatment for Substance Use Disorders and Hepatitis C in an Addiction Treatment Service in India

Proteomic-based identification of APCS as candidate protein for diagnosis of patients exhibiting anti-tubercular drug induced liver injury

P1- HIGH VIRAL SUPPRESSION AND IMPROVED SAFETY PROFILE OF TENOFOVIR ALAFENAMIDE RELATIVE TO TENOFOVIR DISOPROXIL FUMARATE IN CHRONIC HEPATITIS B PATIENTS TREATED FOR 5 YEARS

Association between nonalcoholic fatty liver disease and inflammatory periodontal disease: A case‑control study

GALAD Score for HCC Screening and Surveillance

Nonalcoholic Fatty Liver Disease: Indian Perspective

Su1537 MACHINE LEARNING ADVANCED FIBROSIS AND AT-RISK MASH (ALADDIN) WITH A WEB-BASED CALCULATOR FOR PROBABILITY PREDICTION

Phospho zinc finger protein: A promising serum biomolecule as noninvasive diagnostic marker of chronic Hepatitis B related liver diseases including liver cancer

Substantial overlap between NAFLD and MASLD with comparable disease severity and non-invasive test performance: An analysis of the Indian Consortium on MASLD (ICOM-D) cohort

I. Beta-blockers: Finding the Right Timing and its Role in Cirrhosis

MASLD screening and diagnostic algorithms are interchangeable with existing NAFLD literature

Special Population

Obesity and NAFLD

Role of radiofrequency ablation in unresectable hepatocellular carcinoma: An Indian experience

Mo1537 NIAAA CLINICAL CRITERIA FOR THE DIAGNOSIS OF ALCOHOLASSOCIATED HEPATITIS ARE PRECISE IN SEVERE BUT NOT IN MODERATE ALCOHOL-ASSOCIATED HEPATITIS

A prospective observational study on the impact of hepatic steatosis, hepatic fibrosis, and metabolic syndrome on the outcome of patients with acute pancreatitis

S1430 Saroglitazar Improves Metabolic Profile, Hepatic Steatosis, Inflammation, and Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: A Systematic Review

Calorie restriction by time restricted intermittent fasting is better than standard calorie restriction in improving the metabolic profile and hepatic fibrosis in patients with non-alcoholic fatty liver disease

Aktive Filter

Suchergebnisse filtern